Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;19(12):5742-5754.
doi: 10.1002/alz.13358. Epub 2023 Jul 12.

Associations of dietary cholesterol and fat, blood lipids, and risk for dementia in older women vary by APOE genotype

Affiliations

Associations of dietary cholesterol and fat, blood lipids, and risk for dementia in older women vary by APOE genotype

Michelle M Dunk et al. Alzheimers Dement. 2023 Dec.

Abstract

Introduction: Whether apolipoprotein E's (APOE's) involvement in lipid metabolism contributes to Alzheimer's disease (AD) risk remains unknown.

Methods: Incident probable dementia and cognitive impairment (probable dementia+mild cognitive impairment) were analyzed in relation to baseline serum lipids (total, low-density lipoprotein [LDL], high-density lipoprotein [HDL], non-HDL cholesterol, total-to-HDL, LDL-to-HDL, remnant cholesterol, and triglycerides) using Mendelian randomization in 5358 postmenopausal women from the Women's Health Initiative Memory Study. We also examined associations of baseline dietary cholesterol and fat with lipids based on APOE status.

Results: After an average of 11.13 years, less favorable lipid levels related to greater dementia and cognitive impairment risk. Dementia (odds ratio [OR] = 3.13; 95% confidence interval [CI]: 2.31 to 4.24) and cognitive impairment (OR = 2.38; 95% CI: 1.85 to 3.06) risk were greatest in relation to higher remnant cholesterol levels. Greater cholesterol consumption related to poorer lipids in APOE4+ compared to APOE3 carriers.

Discussion: APOE4+ carriers consuming more cholesterol had less favorable lipids, which were associated with greater dementia and cognitive impairment risk.

Highlights: Less favorable serum lipids were associated with higher dementia incidence. Mendelian randomization findings suggest causality between lipids and dementia. Lipid levels in older women may be clinical indicators of dementia risk. APOE4 carriers had poorest lipid profiles in relation to cholesterol consumption. APOE risk for dementia may be modifiable through lipid management.

Keywords: Alzheimer's disease; Mendelian randomization; apolipoprotein E; cholesterol; dementia; diet; mild cognitive impairment; women's health initiative memory study.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

All authors have no disclosures to report related to this work.

Figures

Figure 1.
Figure 1.. APOE Significantly Modifies the Relationships Between Diet and Lipids.
Greater consumption of dietary cholesterol was associated with greater higher LDL, non-HDL, LDL-to-HDL, and total-to-HDL cholesterol levels in APOE4+ compared to APOE3 carriers. Greater consumption of monounsaturated fat and trans fat were associated with higher and lower HDL cholesterol levels, respectively, in APOE2+ compared to APOE3 carriers. SI conversion factor: To convert cholesterol levels to mmol/L, multiply values by 0.0259. To convert triglyceride levels to mmol/L, multiply values by 0.0113. Abbreviations: HDL = high-density lipoprotein; LDL = low-density lipoprotein.

References

    1. Chartier-Harlin M-C, Parfitt M, Legrain S, et al. Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer’s disease: Analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994;3(4):569–574. doi:10.1093/hmg/3.4.569 - DOI - PubMed
    1. Belloy ME, Napolioni V, Greicius MD. A quarter century of APOE and Alzheimer’s disease: Progress to date and the path forward. Neuron 2019;101(5):820–838. doi:10.1016/j.neuron.2019.01.056 - DOI - PMC - PubMed
    1. Alzheimer’s Association. 2021 Alzheimer’s disease facts and figures. Alzheimers Dement 2021;17(3). doi:10.1002/alz.12328 - DOI - PubMed
    1. Sherzai D, Sherzai A. Preventing Alzheimer’s: Our most urgent health care priority. Am J Lifestyle Med 2019;13(5):451–461. doi:10.1177/1559827619843465 - DOI - PMC - PubMed
    1. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review. Am J Epidemiol 2002;155(6):487–495. - PubMed

Publication types